Kat7通过TLR4/NF-κB信号通路加速了骨关节炎疾病的进展
Zhen Liu1, Lijie Qiu2, Yongqiang Zhang1
1Department of Orthopedics, The First Affiliated Hospital of Weifang Medical University (Weifang People's Hospital), Weifang, 261000, China.
概括
参与骨关节炎 (OA) 的蛋白质Kat7在受影响的软骨中被上调. 减少Kat7的表达保护了软骨,并通过抑制TLR4/NF-κB通路来减缓OA的进展.
科学领域:
- 生物化学 生化学
- 分子生物学分子生物学
- 整形外科 整形外科 整形外科
背景情况:
- 骨关节炎 (OA) 是一种常见的退行性关节疾病,其机制尚未完全理解.
- 目前对关节炎的治疗方法缺乏临床疗效,这凸显了对新型治疗点的需求.
研究的目的:
- 研究关节炎病变发生过程中基因素乙转移酶Kat7的作用.
- 探索Kat7作为骨关节炎治疗的潜在治疗点.
主要方法:
- 在人类OA软骨和小鼠OA模型中评估了Kat7表达.
- 在体外和体内利用了状细胞特异性KAT7的淘汰.
- 研究了Kat7对状细胞功能,软骨代谢和OA进展的影响.
- 研究了TLR4/NF-κB信号通路的参与.
主要成果:
- 在OA软骨中,Kat7表达升高,并由关节不稳定引起.
- 特定于冠状细胞的Kat7突击保护关节软骨完整性.
- 卡特7促进了软骨代谢,冠状细胞衰老和亡.
- 沉默Kat7增强了软骨的合成,防止了损伤,并减缓了体内OA的进展.
- Kat7激活了TLR4/NF-κB通路,从而调解了其代谢作用.
结论:
- Kat7在骨关节炎的发展和进展中起着至关重要的作用.
- 向Kat7,可能通过抑制TLR4/NF-κB通路,为骨关节炎提供了一个有前途的治疗策略.
关键词:
软骨的新陈代谢希斯乙转移酶的基因组Kat7 Kat7 Kat7 Kat7 Kat7 Kat7 Kat7 Kat7 Kat7 Kat7 Kat7 Kat7 Kat7 Kat7 Kat7骨关节炎是一种骨关节炎.通过TLR4/NF-κB信号通路传递信号.更多相关视频
相关概念视频
The JAK-STAT Signaling Pathway
8.6K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.6K
T Cell Types and Functions
942
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
942
NF-κB-dependent Signaling Pathway
7.2K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.2K


